DEA MATE Opioid and Substance Use for Practitioners

This course meets the 8-hour training requirement for Drug Enforcement Administration (DEA) registered practitioners such as physicians, physician assistants, nurse practitioners, dentists, and others relevant to the Medication Access and Training Expansion (MATE) Act (Section 1263 of the Consolidated Appropriations Act [CAA] of 2023).

This course discusses evidence-based strategies and best practices for preventing, treating, and mitigating substance use disorder (SUD) or opioid use disorder (OUD), as well as legal and ethical considerations related to effective pain management and opioid handling.

Learning Objectives

  • Recall legal requirements for opioid prescribing and handling
  • Apply key recommendations and best practices, restrictions, and requirements for prescribing opioids for pain management
  • Specify essential client education and conversations related to use of opioids for pain management, including safety, storage, and disposal information
  • Identify how geographic, ethnic, and socioeconomic health disparities and biases affect appropriate and equitable pain assessment, treatment, and management
  • Identify the best use of screening tools for substance use disorder (SUD)
  • Describe how to identify risk for, diagnose, and appropriately treat someone with opioid overdose, opioid use disorder (OUD), or SUD
  • Evaluate the process and functions of state Prescription Drug Monitoring Programs (PDMPs)
  • Identify techniques for building mutual respect between the client, family, and care team responsible for treatment of OUD or SUD
  • Explain potential treatment benefits and pitfalls of medication-assisted treatment (MAT) programs to treat OUD or SUD
  • List strategies that align with HIPPA or the 42 CFR Part 2 (Final Rule) for maintaining the confidentiality of clients and their protected health information (PHI) while undergoing treatment for OUD or SUD

Additional Information

Partner: 
HealthStream
Course summary
Available credit: 
  • 8.00 AMA PRA Category 1 Credit™
  • 8.00 ANCC
Course opens: 
12/11/2023
Course expires: 
09/25/2026
Cost:
$149.00
Rating: 
0

HealthStream designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational offering is provided by HealthStream CNE Provider Unit. HealthStream CNE Provider Unit is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. ANCC Provider Number: P0088. This activity is awarded 8.0 contact hours; 0.0 contact hours are in pharmacology.

Available Credit

  • 8.00 AMA PRA Category 1 Credit™
  • 8.00 ANCC

Price

Cost:
$149.00
Please login or register to take this course.

This course is offered through HealthStream. To take this course you will be redirected to HealthStream's website. You must have an account with HealthStream in order to complete this activity. 

Mocingbird continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!